Hostname: page-component-745bb68f8f-d8cs5 Total loading time: 0 Render date: 2025-01-12T04:17:36.131Z Has data issue: false hasContentIssue false
  • English
  • Français

Neuroleptic malignant syndrome

Published online by Cambridge University Press:  02 January 2018

Andrew J. Larner
Andrew J. Larner*
Affiliation:
The Midland Centre for Neurosurgery & Neurology, Holly Lane, Smethwick, Warley, West Midlands B67 7JX
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Information
The British Journal of Psychiatry , Volume 160 , Issue 6 , June 1992 , pp. 868
Copyright
Copyright © The Royal College of Psychiatrists 

References

Caroff, S., Rosenberg, H. & Gerber, J. C. (1983) Neuroleptic malignant syndrome and malignant hyperthermia. Lancet, i, 244.Google Scholar
Hopkins, P. M., Ellis, F. R. & Halsall, P. J. (1991) Ryanodine contracture: a potentially specific in vitro diagnostic test for malignant hyperthermia. British Journal of Anaesthesia, 66, 611–613.Google Scholar
Jones, E. M. & Dawson, A. (1989) Neuroleptic malignant syndrome: a case report with post-mortem brain and muscle pathology. Journal of Neurology, Neurosurgery and Psychiatry, 52,1006–1009.Google Scholar
Larner, A. J. (1992) Dantrolene for exertional heatstroke Lancet, 339, 182.Google Scholar
Mickelson, J. R., Gallant, E. M., Litterer, L. A., et al (1988) Abnormal sarcoplasmic reticulum ryanodine receptor in malignant hyperthermia. Journal of Biological Chemistry, 263, 9310–9315.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.